Clinical Trial Phases

Mahan, Vicki L. (2014) Clinical Trial Phases. International Journal of Clinical Medicine, 05 (21). pp. 1374-1383. ISSN 2158-284X

[thumbnail of IJCM_2014122915372964.pdf] Text
IJCM_2014122915372964.pdf - Published Version

Download (2MB)

Abstract

Developers of drugs, biologicals, and medical devices must ensure product safety, demonstrate medical benefit in people, and mass produce the product. Preclinical development starts before clinical trials and the main goals are to determine safety and effectiveness of the intervention. If preclinical studies show that the therapy is safe and effective, clinical trials are started. Clinical trial phases are steps in the research to determine if an intervention would be beneficial or detrimental to humans and include Phases 0, I, II, III, IV, and V clinical studies. Understanding the basis of clinical trial phases will help researchers plan and implement clinical study protocols and, by doing so, improve the number of therapies coming to market for patients.

Item Type: Article
Subjects: GO STM Archive > Medical Science
Depositing User: Unnamed user with email support@gostmarchive.com
Date Deposited: 19 Jan 2023 12:19
Last Modified: 13 Jun 2024 13:31
URI: http://journal.openarchivescholar.com/id/eprint/22

Actions (login required)

View Item
View Item